J 2018

Differential diagnosis of the small renal masses: role of the apparent diffusion coefficient of the diffusion-weighted MRI

MYTSYK, Yulian, Ihor DUTKA, Borys YURIY, Iryna MAKSYMOVYCH, Martin CAPRNDA et. al.

Základní údaje

Originální název

Differential diagnosis of the small renal masses: role of the apparent diffusion coefficient of the diffusion-weighted MRI

Autoři

MYTSYK, Yulian (804 Ukrajina, garant), Ihor DUTKA (804 Ukrajina), Borys YURIY (804 Ukrajina), Iryna MAKSYMOVYCH (804 Ukrajina), Martin CAPRNDA (703 Slovensko), Katarina GAZDIKOVA (703 Slovensko), Luis RODRIGO (724 Španělsko), Peter KRUŽLIAK (703 Slovensko, domácí), Polina ILLJUK (804 Ukrajina) a Ammad Ahmad FAROOQI (586 Pákistán)

Vydání

International Urology and Nephrology, Dordrecht, Springer, 2018, 0301-1623

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30217 Urology and nephrology

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 1.596

Kód RIV

RIV/00216224:14110/18:00102965

Organizační jednotka

Lékařská fakulta

DOI

UT WoS

000425010000002

Klíčová slova anglicky

Small renal masses; Renal cell carcinoma; MRI; Diffusion-weighted imaging; Apparent diffusion coefficient

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 9. 2. 2019 22:13, Soňa Böhmová

Anotace

V originále

Renal cell carcinoma (RCC) accounts for approximately 3% of adult malignancies and more than 90% of neoplasms arising from the kidney. Uninformative percutaneous kidney biopsies vary from 10 to 23%. As a result, 7.5-33.6% of partial nephrectomies in patients with small renal masses (SRM) are performed on benign renal tumors. The aim of this study was to assess the feasibility of the apparent diffusion coefficient (ADC) of the diffusion-weighted imaging (DWI) of MRI, as RCC imaging biomarker for differentiation of SRM. Adult patients (n = 158) with 170 SRM were enrolled into this study. The control group were healthy volunteers with normal clinical and radiologic findings (n = 15). All participants underwent MRI with DWI sequence included. Mean ADC values of solid RCC (1.65 +/- 0.38 x 10(-3) mm(2)/s) were lower than healthy renal parenchyma (2.47 +/- 0.12 x 10(-3) mm(2)/s, p < 0.05). There was no difference between mean ADC values of ccRCC, pRCC and chRCC (1.82 +/- 0.22 x 10(-3) vs 1.61 +/- 0.07 x 10(-3) vs 1.46 +/- 0.09 x 10(-3) mm(2)/s, respectively, p = ns). An inverse relationship between mean ADC values and Fuhrman grade of nuclear atypia of solid ccRCCs was observed: grade I-1.92 +/- 0.11 x 10(-3) mm(2)/s, grade II-1.84 +/- 0.14 x 10(-3) mm(2)/s, grade III-1.79 +/- 0.10 x 10(-3) mm(2)/s, grade IV-1.72 +/- 0.06 x 10(-3) mm(2)/s. This was significant (p < 0.05) only between tumors of I and IV grades. Significant difference (p < 0.05) between mean ADC values of solid RCCs, benign renal tumors and renal cysts was observed (1.65 +/- 0.38 x 10(-3) vs 2.23 +/- 0.18 x 10(-3) vs 3.15 +/- 0.51 x 10(-3) mm(2)/s, respectively). In addition, there was a significant difference (p < 0.05) in mean ADC values between benign cysts and cystic RCC (3.36 +/- 0.35 x 10(-3) vs 2.83 +/- 0.21 x 10(-3) mm(2)/s, respectively). ADC maps with b values of 0 and 800 s/mm(2) can be used as an imaging biomarker, to differentiate benign SRM from malignant SRM. Using ADC value threshold of 1.75 x 10(-3) mm(2)/s allows to differentiate solid RCC from solid benign kidney tumors with 91% sensitivity and 89% specificity; ADC value threshold of 2.96 x 10(-3) mm(2)/s distinguishes cystic RCC from benign renal cysts with 90% sensitivity and 88% specificity. However, the possibility of differentiation between ccRCC histologic subtypes and grades, utilizing ADC values, is limited.